Vimy Pharma key facts
- Manufacturers of pharmaceutical medicines intended to improve treatment and support healthcare systems.
- Notable investors include K2 & Associates Investment Management.
- Status: Privately Held (backing).
Who backs Vimy Pharma
1- ·Watch Vimy Pharma: the Monday email on marks, rounds and moves
Vimy Pharma funding rounds
No funding rounds for Vimy Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Vimy Pharma investors
1 investor is on record for Vimy Pharma, including K2 & Associates Investment Management. By type, the record holds 1 hedge fund.
About Vimy Pharma
Manufacturers of pharmaceutical medicines intended to improve treatment and support healthcare systems. The company provides affordable medicines with a focus on supporting the sustainability of publicly funded healthcare systems, alignment with rigorous regulatory and safety standards, efforts to reduce reliance on foreign sources, and support for local manufacturing, enabling healthcare institutions to access affordable treatments for chronic diseases and sustaining domestic supply.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2024
- Website
- vimypharma.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Vimy Pharma doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.